In a chlorpromazine- (CPZ-) induced demyelination mouse model, the progesterone treatment group exhibited a decrease in neurological behavioral deficit scores accompanied by decreased levels of NLRP3 inflammasomes [54]. The gene discussed is NLRP3; the disease is Peripheral demyelination.